Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
254.02
-0.40 (-0.16%)
May 14, 2026, 4:00 PM EDT - Market closed
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
|---|
| 11.01B | 10.88B | 10.14B | | | | | | | | | | | |
Diagnostics (Dx) Revenue Growth | 1.22% | 7.22% | 7.75% | | | | | | | | | | | |
Biopharma Laboratory Services (BLS) Revenue | 3.16B | 3.10B | 2.92B | | | | | | | | | | | |
Biopharma Laboratory Services (BLS) Revenue Growth | 1.91% | 6.01% | 5.35% | | | | | | | | | | | |
| -22.30M | -23.00M | -58.00M | | | | | | | | | | | |
| 14.14B | 13.95B | 13.01B | | | | | | | | | | | |
| 1.38% | 7.25% | 6.97% | | | | | | | | | | | |
EBIT
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
|---|
Diagnostics (Dx) Operating Earnings | 1.81B | 1.78B | 1.61B | | | | | | | | | | | |
Diagnostics (Dx) Operating Earnings Growth | 1.75% | 10.81% | 0.94% | | | | | | | | | | | |
Biopharma Laboratory Services (BLS) Operating Earnings | 512.30M | 498.50M | 458.90M | | | | | | | | | | | |
Biopharma Laboratory Services (BLS) Operating Earnings Growth | 2.77% | 8.63% | 15.80% | | | | | | | | | | | |
| -883.90M | -893.70M | -978.50M | | | | | | | | | | | |
| 1.44B | 1.38B | 1.09B | | | | | | | | | | | |
Operating Income (Total) Growth | 3.96% | 27.42% | 49.77% | | | | | | | | | | | |
Key Performance Indicators
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
|---|
North America % Total Revenue | 87.00% | 87.00% | | | | | | | | | | | |
| 9.00% | 9.00% | | | | | | | | | | | |
Other Geography % Total Revenue | 4.00% | 4.00% | | | | | | | | | | | |
| 4.40% | 3.90% | | | | | | | | | | | |
Updated May 4, 2026. Data Source:
Fiscal.ai.
